MRI and Computational Simulation Cardiology Study

Key facts

Sponsor

Stanford University

Principal Investigator

Jeffrey Feinstein, MD, MPH

Stanford University

Intervention

Magnetic Resonance Imaging(other)

Enrollment

75 target

Eligibility

All sexes

Timeline

2008 – 2029

Study locations (1)

• Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Heritable pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07498244
  Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients
  Medical University of Graz
• RECRUITINGNANCT07079592
  A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
  National Defense Medical Center, Taiwan
• RECRUITINGPHASE4NCT07147114
  Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)
  Gachon University Gil Medical Center
• RECRUITINGPHASE2NCT07073820
  A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
  Pfizer
• RECRUITINGNCT07537517
  Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
  Hospital General Universitario Gregorio Marañon
• RECRUITINGNANCT07120789
  Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
  University of Sao Paulo General Hospital
• RECRUITINGNANCT07576894
  Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
  University of Colorado, Denver
• RECRUITINGNCT07087613
  Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
  Eko Devices, Inc.

See all trials for Heritable pulmonary arterial hypertension →